The most common way to analyze the function of cloned genes in zebrafish is to misexpress the gene product or an altered variant of it by mRNA injection. However, mRNA injection has several disadvantages. The GAL4-UAS system for targeted gene expression allows one to overcome some of these disadvantages. To test the GAL4-UAS system in zebrafish, we generated two different kinds of stable transgenic lines, carrying activator and effector constructs, respectively. In the activator lines the gene for the yeast transcriptional activator GAL4 is under the control of a given promoter, while in the effectors the gene of interest is fused to the sequence of the DNA-binding motif of GAL4 (UAS). Crosses of animals from the activator and effector lines show that effector genes are transcribed with the spatial pattern of the activators. This work smoothes the way for a novel method of misexpression of gene products in zebrafish in order to analyze the function of genes in developmental processes.
Introduction
In the last few years, the zebrafish Danio rerio has become a popular model organism for studying vertebrate development, chiefly because it combines some of the benefits of the genetically tractable mouse system with the embryological advantages of amphibians (Kimmel, 1989; Rossant and Hopkins, 1992; Driever et al., 1994) . However, a very important disadvantage as compared with the mouse is the absence of a technique for altering the function of a known gene by targeted modification. As in Xenopus (e.g. Harvey and Melton, 1988; Kintner, 1988; Chitnis et al., 1995) , the most common way to analyze the function of any gene cloned in the zebrafish is to misexpress its wildtype product, or an altered variant of it, by mRNA injection into blastomeres. This method rapidly yields insights into the developmental function of a gene, but it also suffers from some inconveniences. Thus, mRNA injections are unspecific with regard to the tissue and developmental stage of expression. That is to say, injections in blastomeres generally lead to the synthesis of the product in all the progeny of the injected cell. This makes it difficult to determine the function of a gene product in any given process. In addition, if the gene product plays a role during early stages of embryogenesis, the phenotypic consequences may obscure the effects on later stages.
So far no methods are available that allow one to misexpress a gene product in the zebrafish in a directed stage-and tissue-specific manner. In Drosophila, on the other hand, one such method -the GAL4-UAS system (Fischer et al., 1988; Brand and Perrimon, 1993) -is routinely used to analyze the function of developmental genes (e.g. Brand, 1995; Brand and Dormand, 1995) . The technique is based on two different kinds of transgenic strains, called activator and effector lines. In an activator line the gene for the yeast transcriptional activator GAL4 is placed under the control of a specific promoter, while in the effector line the gene of interest is fused to the DNA-binding motif of GAL4 (Upstream Activating Sequences, UAS). The effector gene will be transcriptionally silent unless animals carrying it are crossed to those of an activator line. In the progeny of this cross, expression of the effector gene will reflect the pattern of expression of GAL4 in the activator, which is ultimately dependent on the promoter that has been used to control it. This, of course, allows controlled ectopic expression of the effector gene. The use of activators with different expressivities, which arise due to positional effects acting on the activator construct, allows the experimenter to exploit a relatively wide range of levels of effector gene expression.
The establishment of the GAL4-UAS method for targeted gene expression in zebrafish is highly desirable for several reasons. A steadily increasing number of genes cloned from zebrafish could then be analyzed in more detail than is feasible with mRNA injections. Expression of GAL4 in a variety of stages and tissues will become possible in the near future, since more and more promoters and tissue-specific enhancer sequences will be isolated from zebrafish. As new activators and effectors become available -due to the combinatorial nature of the method -a large variety of processes will become amenable to analysis, just by crossing these different transgenic lines with each other.
However, since the published literature on transgenesis in zebrafish does not allow one to make any reliable predictions about how efficiently transgenes are expressed, there are some possible obstacles to the application of the approach. Although Stuart et al. (1990) observed similar patterns of CAT expression in tissues of independent transgenic lines using a viral promoter (RSV-LTR), studies at the cellular level, assayed using an anti-CAT antibody, revealed a highly variegated expression pattern. Furthermore silencing of transgenes following passage into the F1 and during subsequent generations has been noted by several groups (Culp et al., 1991; Bayer and Campos-Ortega, 1992; Hackett, 1993) . More recent results with zebrafish promoters indicate, however, that these problems might be due to the use of heterologous sequences (Higashijima et al., 1997; Long et al., 1997) .
This work is a pilot project to test the functionality and efficacy of the GAL4-UAS system in zebrafish. We have constructed transgenic activator and effector lines, and show that, although heterologous promoters were used, all activator constructs are expressed and transgenic GAL4 can efficiently activate transcription of the effector genes in the cells in which it is synthesized.
Results and discussion
To generate transgenic zebrafish lines, two different kinds of constructs were made (Fig. 1) . For the activator constructs two different promoters were used to express GAL4 (Fig. 1a) . The svtk promoter contains an enhancer element from the SV40 virus and the thymidine kinase promoter from Herpes simplex, which has been shown to be strongly and ubiquitously expressed in transient essays in Medaka (Winkler, 1993) . The carp b-actin promoter had been previously reported to drive ubiquitous expression in transgenic zebrafish lines when combined with the matrix attachment region (MAR) of the chicken lysozyme locus (Caldovic and Hackett, 1995) . Since MARs are also thought to minimize positional effects of the integration site on the transgenes (Stief et al., 1989; Bonifer et al., 1990; Bonifer et al., 1994; Phi-Van et al., 1990; McKnight et al., 1992; Caldovic and Hackett, 1995; Phi-Van and Stratling, 1996) , we included them in our constructs. In some activator constructs only one set of MAR sequences is present, in others MAR sequences are present on both sides of the constructs. The effector construct that we used (Fig. 1b) is also flanked by MARs. As the effector gene we used myc-notch1:intra, which codes for a protein in which six myc epitopes are fused to the intracellular domain of the zebrafish notch1 protein (Bierkamp and Campos-Ortega, 1993; Takke et al., submitted) . The coding region is under the control of five copies of an optimized UAS from yeast and the minimal E1b promoter of adenovirus (Argenton et al., 1996) . We added a synthetic transcriptional start site from the carp bactin promoter 25 bp downstream of the TATA box. Activator and effector constructs were designed in such a way that they can be excised from the vector by cleavage with NotI and Asp718.
Fertilized egg cells were injected with this DNA. Injected fish were raised to sexual maturity and crossed with unin- jected fish. Then their progeny were screened by the polymerase chain reaction (PCR) to detect germ-line transmission of the different constructs. Positive founder fish were crossed again to uninjected fish, and F1 positive individuals identified by PCR analysis of genomic DNA prepared from fin fragments. The frequency of transgenic founders was found to be in a range of 5 to 10% of the individuals that survived the injections (Table 1) . Due to germ-line mosaicism, 2-40% of the F1 offspring of the transgenic founders carried the transgene in their fins (data not shown).
Transgenic activator constructs are transcribed
GAL4 transcripts were detected in embryos of transgenic activator strains by in situ hybridization using a digoxigeninlabelled GAL4-RNA probe. Individuals from one of two transgenic lines with the svtk promoter (Table 1) exhibit only very weak expression in a few cells of the embryo (not shown), while those from the other line express GAL4 RNA at high levels in the cells of the enveloping layer and in various expression domains in the hindbrain ( Fig. 2A,B and F). The expression in animals of the first line is reminiscent of the results of previous investigations that used viral promoters (Stuart et al., 1990; Culp et al., 1991) , while the expression pattern of the second had not previously been observed with viral promoters. No qualitative differences were observed in the pattern of expression among transgenic lines bearing the carp b-actin promoter (a total of seven, Table 1 ), irrespective of the number of MAR sequences present in the construct, i.e. either one or two. GAL4 expression was observed in the cells of the adaxial mesoderm and in a specific expression domain in the hindbrain, expression was restricted to the time window between the 1-somite stage and 24 h of development (Fig. 2D) .
Expressivity varies significantly between the different activator lines, being stronger in some lines than in others. Using MARs and the carp b-actin promoter, Caldovic and Hackett (1995) observed ubiquitous expression with anti-CAT antibodies. The restricted expression that we observe is not easy to interpret. One possible explanation is differential sensitivity of the methods used to detect expression. It cannot be excluded that we only detect the highest level of expression by in situ hybridization. Longer periods of staining, however, led to a high background that could not be distinguished from any additional specific signal.
Transgenic GAL4 activates transcription of the effector gene
The first indication that transgenic GAL4 can activate transcription of the effector gene derives from transient expression essays. About 5 nl of plasmid DNA (50 ng/ml) of the effector construct UAS-myc-notch:intra were injected into zygotes of the different activator strains and of the wild-type. Activation of the effectors was detected by staining with anti-myc antibody. Virtually every injected embryo showed expression after injection into zygotes carrying the transgenic effectors; although mosaic expression was noted in these animals, tissues in which GAL4-RNA had been shown to be transcribed always expressed the effector (data not shown). No expression at all was observed following injection into wild-type zygotes.
Further proof of the functionality of the system was obtained by crossing fish bearing the myc-notch:intra effector with any of the activator lines ( Table 2) . Expression of the effector gene was detected by anti-myc antibody staining in the progeny of the crosses.
Only four of the five independent myc-notch:intra transgenic lines have been tested so far and in all of them the effector gene was transactivated in the presence of GAL4 (Table 2) . Of the seven independent activator lines tested (Table 2) , five were capable of transactivating expression of the effector construct, whereas the other two did not. One of the latter is the svtk line in which GAL4-RNA is expressed at very low levels in just a few cells of the embryo (see above). In this case expression might be too low for transactivation to occur, even if a functional protein is made. However, embryos of the other line carry the carp b-actin promoter and exhibit GAL4 RNA expression at high levels, similar to those of other lines that are able to transactivate, so that in this case we assume that no functional protein is made. In the five lines that showed transactivation, expression of the effector gene mimics the expression of GAL4 in the activators (Fig. 2C,E and G) . However, a slight delay is observed in the expression of the effector gene relative to that of the activator.
Conclusions
We have thus far shown that, using the constructs described here, the GAL4-UAS system works efficiently in zebrafish. Progeny of crosses of five activator lines with four effector lines tested so far showed transactivation of myc;notch:intra. Neither the activator nor the effector constructs appear to have suffered any modification on passing through the germ line; expression in these lines continues to be stable in the third generation. Whether this behaviour is due to the MARs that have been used in our study cannot be judged from this work, since no transgenic lines without MAR-SVTK-GAL4-polyA 41 2 (5) MAR-carp b-actin-GAL4-polyA 49 5 (10) MAR-carp b-actin-GAL4-polyA-MAR 18 2 (11) MAR-UAS-myc-notch:intrapolyA-MAR 58 5 (9) these sequences were generated. This will be the subject of further investigation. The phenotypic effects of the misexpression of the intracellular domain of notch1 are currently being analyzed.
Materials and methods

Construction of activator and effector plasmids
For the construction of the activator plasmids the HindIII fragment of GAL4 from pGATB (Brand and Perrimon, 1993 ) was fused to the SV40 small intron and polyadenylation site, and either the XbaI/Asp718 carp b-actin promoter fragment from pFV3CAT (Caldovic and Hackett, 1995) , or the XbaI/SalI SVTk promoter from pSVTk lacZ (Winkler, 1993) , was cloned upstream of the translational start site of GAL4. These promoter-GAL4-SV40polyA fragments were cloned either into a plasmid with one MAR (pBsMAR) or in between two MARs (pBs2MAR) oriented as direct repeats. The backbone plasmid vectors were pBluescript (KS) in both cases.
The myc-Notch:intra effector constructs were generated by fusing a myc-Notch:intra-SV40polyA fragment (a gift of activator; E and G are anti-myc antibody stainings in the progeny from the cross between activator and effector strains. During early stages (A, 1-somite; B-C, 4-somite), GAL4 is expressed in a band of neural plate cells (arrows in A, B and C) in a region located caudal to the midbrain-hindbrain boundary, i.e. within the rhombencephalic primordium. In later stages (F, around 24 h), expression is visible in the rhombomeric boundaries (arrows in F). In addition, GAL4 is also strongly expressed in the cells of the external enveloping layer (evl, most cells are out of focus) throughout embryogenesis. In the activator lines (D) GAL4 is strongly transcribed in the adaxial mesoderm (am). myo, Myotome. Embryos from all lines transgenic for either construct showed the same GAL4 spatial transcription pattern, but different for each construct. C, E and G show anti-myc antibody stainings of embryos progeny of crosses between fish carrying activator and effector constructs. Notice that the distribution of the myc-epitope is virtually identical to the pattern of GAL4 transcription. P. Dornseifer) to 5 × UASg-Elb TATA from pN5 × UASgLuc (a gift of F. Argenton). A synthetic oligonucleotide of 45 bp (Eurogentec) was inserted between the E1b minimal promoter and myc-notch:intra, so that a transcriptional start site from a fish promoter (carp b-actin) is located 25 bp downstream of the TATA box. The 5 × UASg-Elb -mycnotch:intra -SV40polyA fragment was cloned between the two MARs of pBs2MAR. Further structural details of the activator and effector plasmids are available upon request.
DNA preparation and microinjection
To obtain DNA fragments for injection, plasmids were digested with NotI/Asp718, which excise the fragments from the vector. Fragments were separated by electrophoresis on an agarose gel, recovered from the gel using the QIAEX II Gel Extraction Ki (QIAGEN), purified on a tip 100 (QIAGEN) and dissolved in distilled water. Approximately 5 nl of DNA solution (about 50 ng/ml) containing 0.2% phenol red was injected into the cytoplasm of 1-cell zebrafish embryos.
DNA isolation and PCR analyst
For detection of transgenic founder fish, genomic DNA from pools of F1 embryos (24-h old) was isolated according to Westerfield (1994) . PCR analysis was carried out using primers specific for each of the constructs. The cycling conditions were: an initial 3 min denaturation step at 93°C followed by 3 cycles of 93°C for 1 min, annealing for 1 min, 72°C for 1 min, then 33 cycles of 93°C for 1 min, annealing for 50 s, 72°C for 50 s and a final extension step at 72°C for 7 min. The annealing temperature was different for each pair of primers.
In situ hybridization and immunochemistry
Hybridization of digoxygenin-labelled GAL4 RNA probes to embryo wholemounts was performed as described (Bierkamp and Campos-Ortega, 1993) . For this purpose the HindIII GAL4 fragment from pGATB was cloned into the HindIII site in pBluescipt (KS) and digoxygenin-labelled GAL4 RNA probes were prepared using an RNA labelling kit (Boehringer-Mannheim). Antibody staining of the embryos was performed as described by Westerfield (1993) , with some modifications. The embryos were first treated with a hybridoma supernatant containing the monoclonal anti-myc antibody (1:2). The secondary antibody was a HRP-linked goat anti-mouse antiserum (1:500). Table 2 Transactivation by different activators of the myc-notch:intra effector construct. The results refer to four transgenic effector lines
Construct
Tested lines
Transactivation
No transactivation MAR-svtk-GAL4-polyA 2 1 1 MAR-carp b-actin-GAL4-polyA 4 3 1 MAR-carp b-actin-GAL4-polyA-MAR 1 1 0 7 5 2
